Varsinais-Suomen wellbeing region pharmaceutical procurement group: Aflibercept 40 mg/ml injection solution procurement for the period 1.1.2027-31.12.2027
Varsinais-Suomen hyvinvointialueen lääkehankintarengas: Aflibersepti 40 mg/ml injektionesteiden hankinta kaudelle 1.1.2027-31.12.2027
Finland · Turku · how to bid here →
Your path to submission
- Deadline: 2 November at 12:00 — 26 days left.
- You submit on Hilma — not here and not by e-mail. ↗
- Offer and evidence in: FIN.
- Collect your evidence — the eligibility requirements are listed above; for many of them the analysis explains how to obtain them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every month (489 awards, most recently September 2026) — the next award is due around November 2026 by that rhythm. The last award went to Cardirad Oy.n = 489
- 47% of this buyer's awards went to companies that had already won here before (1,035 awards since 2022, spread over 510 companies). 53% went to new names.n = 1,035 awards since 2022
- The award came in at a median 102% of the estimated value (14 awards with both estimate and value) — pricing at the estimate is usually about right here. Sector: 83%.n = 14
- The median procedure drew 4 bids (615 procedures with a bid count); 17% ended with a single bidder. Sector: median 4 bids.n = 615
- 2% of awards went to companies from abroad (1,035 awards with a known winner country). Sector average: 5%.n = 1,035
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 04/10/2026.
Foreign bidders
In Finland · Medical equipment & pharma, 261 contracts went to foreign companies over the last 3 years (of 7,199 recorded awards) — mostly from Sweden, Germany, Denmark.
Typical field: median 4 (from 286 awards).
What the buyer is looking for
Pharmaceutical procurement ring of the wellbeing services county of Southwest Finland: Acquisition of aflibersepti 40 mg/ml injections for the period 1.1.2027-31.12.2027 The procurement concerns aflibersepti 40 mg/ml injection products in the well-being areas of Southwest Finland, Satakunta and Ostrobothnia and Ålands Hälso- och sjukvård (ÅHS) in the pharmaceutical procurement ring for the period 1.1.2027-31.12.2027. A more detailed description of the procurement in the invitation to tender.,
Selection criteria — in the procurement documents
The buyer states in the notice that the selection criteria are in the procurement documents (link on the right), not in the EU form. The document analysis below extracts them from there — bid and evidence in Finnish.
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| GE Healthcare Finland Oy · HELSINGFORS | 24 | 2024–2026 |
| Olympus Finland Oy | 18 | 2024–2026 |
| Medtronic Finland Oy · VANDA | 15 | 2024–2026 |
| Abbott Medical Finland Oy (0974264-1)//Abbott Medical Finland Oy (0974264-1)//Boston Scientific Nordic AB (2520562-7)//Medtronic Finland Oy (1514187-7)//Boston Scientific Nordic AB (2520562-7)//Medtronic Finland Oy | 15 | 2023–2026 |
| B. Braun Medical Oy | 15 | 2024–2026 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.